Michael Wagner

Mild-to-moderate psoriasis is associated with subclinical inflammation in the duodenum and a tendency of disturbed intestinal barrier

Lundquist, Patrik; Hagforsen, Eva; Wagner, Michael; Alimohammadi, Mohammad et al.

Part of Biochimica et Biophysica Acta - Molecular Basis of Disease, 2025

• DOI for Mild-to-moderate psoriasis is associated with subclinical inflammation in the duodenum and a tendency of disturbed intestinal barrier
• Download full text (pdf) of Mild-to-moderate psoriasis is associated with subclinical inflammation in the duodenum and a tendency of disturbed intestinal barrier

Automated GMP-Compliant Production of [Ga-68]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans

Wagner, Michael; Doverfjord, Johan G.; Tillner, Joachim; Antoni, Gunnar et al.

Part of Pharmaceuticals, 2020

• DOI for Automated GMP-Compliant Production of [Ga-68]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans
• Download full text (pdf) of Automated GMP-Compliant Production of [Ga-68]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans

Increased Fecal Levels of Chromogranin A, Chromogranin B and Secretoneurine in Collagenous Colitis

Wagner, Michael; Stridsberg, Mats; Peterson, Christer G B; Sangfelt, Per et al.

Part of Inflammation, p. 855-861, 2013

• DOI for Increased Fecal Levels of Chromogranin A, Chromogranin B and Secretoneurine in Collagenous Colitis

Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: A pilot study

Wagner, Michael; Peterson, Christer GB; Stolt, Ingrid; Sangfelt, Per et al.

Part of Scandinavian Journal of Gastroenterology, p. 849-854, 2011

• DOI for Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: A pilot study

Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation

Biglarnia, Ali-Reza; Nilsson, Bo; Nilsson, Thomas; von Zur-Mühlen, Bengt et al.

Part of Transplant International, 2011

• DOI for Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation

Mild-to-moderate psoriasis is associated with subclinical inflammation in the duodenum and a tendency of disturbed intestinal barrier

Lundquist, Patrik; Hagforsen, Eva; Wagner, Michael; Alimohammadi, Mohammad et al.

Part of Biochimica et Biophysica Acta - Molecular Basis of Disease, 2025

• DOI for Mild-to-moderate psoriasis is associated with subclinical inflammation in the duodenum and a tendency of disturbed intestinal barrier
• Download full text (pdf) of Mild-to-moderate psoriasis is associated with subclinical inflammation in the duodenum and a tendency of disturbed intestinal barrier

Automated GMP-Compliant Production of [Ga-68]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans

Wagner, Michael; Doverfjord, Johan G.; Tillner, Joachim; Antoni, Gunnar et al.

Part of Pharmaceuticals, 2020

• DOI for Automated GMP-Compliant Production of [Ga-68]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans
• Download full text (pdf) of Automated GMP-Compliant Production of [Ga-68]Ga-DO3A-Tuna-2 for PET Microdosing Studies of the Glucagon Receptor in Humans

Increased Fecal Levels of Chromogranin A, Chromogranin B and Secretoneurine in Collagenous Colitis

Wagner, Michael; Stridsberg, Mats; Peterson, Christer G B; Sangfelt, Per et al.

Part of Inflammation, p. 855-861, 2013

• DOI for Increased Fecal Levels of Chromogranin A, Chromogranin B and Secretoneurine in Collagenous Colitis

Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: A pilot study

Wagner, Michael; Peterson, Christer GB; Stolt, Ingrid; Sangfelt, Per et al.

Part of Scandinavian Journal of Gastroenterology, p. 849-854, 2011

• DOI for Fecal eosinophil cationic protein as a marker of active disease and treatment outcome in collagenous colitis: A pilot study

Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation

Biglarnia, Ali-Reza; Nilsson, Bo; Nilsson, Thomas; von Zur-Mühlen, Bengt et al.

Part of Transplant International, 2011

• DOI for Prompt reversal of a severe complement activation by eculizumab in a patient undergoing intentional ABO-incompatible pancreas and kidney transplantation

Budesonide Treatment of Patients With Collagenous Colitis Restores Normal Eosinophil and T-cell Activity in the Colon

Wagner, Michael; Lampinen, Maria; Sangfelt, Per; Agnarsdóttir, Margrét et al.

Part of Inflammatory Bowel Diseases, p. 1118-1126, 2010

• DOI for Budesonide Treatment of Patients With Collagenous Colitis Restores Normal Eosinophil and T-cell Activity in the Colon

Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease

Wagner, Michael; Peterson, Christer G. B.; Ridefelt, Peter; Sangfelt, Per et al.

Part of World Journal of Gastroenterology, p. 5584-5589, 2008

• DOI for Fecal markers of inflammation used as surrogate markers for treatment outcome in relapsing inflammatory bowel disease

Clinical and Experimental Studies on Inflammatory Bowel Disease with special emphasis on Collagenous Colitis

Wagner, Michael

2010

• Download full text (pdf) of Clinical and Experimental Studies on Inflammatory Bowel Disease with special emphasis on Collagenous Colitis